Prediction of Single Dose Methotrexate Success in Ectopic Pregnancy Treatment
European Archives of Medical Research · 2019
DOI: 10.4274/eamr.galenos.2018.28199 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Archives of Medical Research, 2019. Verfasst von Berna Aslan Çetin und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To investigate the efficacy of single-dose methotrexate treatment and the factors affecting its success in the treatment of ectopic pregnancy.
Methods
Ectopic pregnancy cases treated with single dose methotrexate treatment between January 2013 and December 2017 were compared as successful and unsuccessful.Demographic characteristics of patients, ectopic mass size, beta human chorionic gonodotropin (β-hCG) values at the beginning of treatment and at 4 th and 7 th days were evaluated.
Results
A total of 462 patients, who underwent single dose methotrexate treatment as initial ectopic pregnancy treatment, were included in the study.Single dose methotrexate treatment was successful in 350 patients (75.8%) and failed in 112 patients (24.2%).Serum β-hCG levels on the day of methotrexate administration, β-hCG values at 4 th day and at 7 th day, and ectopic mass size were significantly higher in the failed group (p
Zitieren
APA
Çetin, B. A., & Mathyk, B. A. (2019). Prediction of Single Dose Methotrexate Success in Ectopic Pregnancy Treatment. European Archives of Medical Research. https://doi.org/10.4274/eamr.galenos.2018.28199
Vancouver
Çetin BA, Mathyk BA. Prediction of Single Dose Methotrexate Success in Ectopic Pregnancy Treatment. European Archives of Medical Research. 2019. doi:10.4274/eamr.galenos.2018.28199
BibTeX
@article{etin2019,
author = {Çetin, Berna Aslan and Mathyk, Begüm Aydoğan},
title = {Prediction of Single Dose Methotrexate Success in Ectopic Pregnancy Treatment},
journal = {European Archives of Medical Research},
year = {2019},
doi = {10.4274/eamr.galenos.2018.28199}
}
EUVIMED